Lucid Diagnostics (LUCD) Return on Equity (2021 - 2026)

Lucid Diagnostics has reported Return on Equity for 6 years, with the latest figure at 0.06% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity rose 8826.0% year-over-year to 0.06%; the trailing twelve-month figure through Mar 2026 stood at 0.06% (up 8826.0% YoY), and the FY2025 full-year result was 0.07%, up 22.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.06%, down from 0.03% in the prior quarter.
• The five-year high for Return on Equity was 0.01% in Q1 2022, with the low at 88.32% in Q1 2025.
• Historically, Return on Equity has averaged 5.51% across 5 years, with a median of 0.03% in 2024.
• Annual changes were most pronounced in 2025 — Return on Equity tumbled 8822 bps — and 2026, when it surged 8826 bps.
• Lucid Diagnostics' Return on Equity stood at 0.02% in 2022, then plunged by 19257 bps to 4.3% in 2023, then soared by 98 bps to 0.08% in 2024, then jumped by 59 bps to 0.03% in 2025, then plunged by 91 bps to 0.06% in 2026.
• The last three Return on Equity figures came in at 0.06% (Q1 2026), 0.03% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.